SCHEMBL3565182

SCHEMBL3565182

Cc1ccc2c(c1)cc(C)n2S(=O)(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.61
PPARA Q07869 5/20 0.61
BRD4 O60885 1/20 0.51
ALDH3A1 P30838 1/20 0.47
ACLY P53396 2/20 0.46
GAA P10253 3/20 0.44
NOD1 Q9Y239 3/20 0.44
NOD2 Q9HC29 2/20 0.44
CXCL8 P10145 2/20 0.44
PPARD Q03181 4/20 0.44
SRC P12931 1/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
FABP4 P15090 1/20 0.43
CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3560088 0.85 ACLY (0.63) PPARGPPARAACLYALDH1A1MAPT
SCHEMBL3563271 0.85 CA12 (0.56) PPARGPPARABRD4ALDH3A1NOD1
SCHEMBL6383467 0.84 HTR6 (0.58) PPARGPPARABRD4ACLYGAA
SCHEMBL3562156 0.84 PPARG (0.61) PPARGPPARABRD4ALDH3A1ACLY
SCHEMBL3563978 0.84 BRD4 (0.49) PPARGPPARABRD4ACLYPPARD
SCHEMBL3560737 0.84 PTGDR2 (0.53) PPARGPPARABRD4ALDH3A1ACLY
SCHEMBL12968247 0.84 BRD4 (0.49) PPARGPPARABRD4ACLYGAA
SCHEMBL15579810 0.84 PPARG (0.55) PPARGPPARABRD4ALDH3A1ACLY
SCHEMBL5801948 0.83 HTR6 (0.48) PPARGPPARABRD4ACLYGAA
SCHEMBL28761637 0.83 PPARG (0.48) PPARGPPARABRD4ALDH3A1ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
US-7507835-B2 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD. (IN) 2009-03-24 US disclosed
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2006-08-03 US disclosed
CN-1720227-A N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD (IN) 2006-01-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT PPARG 1880/4885PPARA 1231/4885BRD4 948/4885
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT PPARG 1880/4885PPARA 1231/4885BRD4 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.